These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 4077932)

  • 1. Suramin binds to platelet-derived growth factor and inhibits its biological activity.
    Hosang M
    J Cell Biochem; 1985; 29(3):265-73. PubMed ID: 4077932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protamine inhibits platelet derived growth factor receptor activity but not epidermal growth factor activity.
    Huang JS; Nishimura J; Huang SS; Deuel TF
    J Cell Biochem; 1984; 26(4):205-20. PubMed ID: 6099364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of cell growth: effects of the tyrosine kinase inhibitor CGP 53716.
    Major TC; Keiser JA
    J Pharmacol Exp Ther; 1997 Oct; 283(1):402-10. PubMed ID: 9336349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suramin interrupts androgen-inducible autocrine loop involving heparin binding growth factor in mouse mammary cancer (Shionogi carcinoma 115) cells.
    Kasayama S; Saito H; Kouhara H; Sumitani S; Sato B
    J Cell Physiol; 1993 Feb; 154(2):254-61. PubMed ID: 7678839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet-derived growth factor labeled to colloidal gold for use as a mitogenic receptor probe.
    Handley DA; Witte LD
    Eur J Cell Biol; 1984 Jul; 34(2):281-6. PubMed ID: 6090144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of platelet-derived growth factor-mediated signal transduction and tumor growth by N-[4-(trifluoromethyl)-phenyl]5-methylisoxazole-4-carboxamide.
    Shawver LK; Schwartz DP; Mann E; Chen H; Tsai J; Chu L; Taylorson L; Longhi M; Meredith S; Germain L; Jacobs JS; Tang C; Ullrich A; Berens ME; Hersh E; McMahon G; Hirth KP; Powell TJ
    Clin Cancer Res; 1997 Jul; 3(7):1167-77. PubMed ID: 9815796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suramin inhibition of growth factor receptor binding and mitogenicity in AKR-2B cells.
    Coffey RJ; Leof EB; Shipley GD; Moses HL
    J Cell Physiol; 1987 Jul; 132(1):143-8. PubMed ID: 3496343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of proliferation of human cerebral meningioma cells by suramin: effects on cell growth, cell cycle phases, extracellular growth factors, and PDGF-BB autocrine growth loop.
    Schrell UM; Gauer S; Kiesewetter F; Bickel A; Hren J; Adams EF; Fahlbusch R
    J Neurosurg; 1995 Apr; 82(4):600-7. PubMed ID: 7897522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA synthesis in U-2 OS human osteosarcoma cells is independent of PDGF binding to functional cell surface receptors.
    Richter MR; Graves DT
    J Cell Physiol; 1988 Jun; 135(3):474-80. PubMed ID: 2840434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms through which gangliosides inhibit PDGF-stimulated mitogenesis in intact Swiss 3T3 cells: receptor tyrosine phosphorylation, intracellular calcium, and receptor binding.
    Yates AJ; VanBrocklyn J; Saqr HE; Guan Z; Stokes BT; O'Dorisio MS
    Exp Cell Res; 1993 Jan; 204(1):38-45. PubMed ID: 8416794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High glucose concentration induces the overexpression of transforming growth factor-beta through the activation of a platelet-derived growth factor loop in human mesangial cells.
    Di Paolo S; Gesualdo L; Ranieri E; Grandaliano G; Schena FP
    Am J Pathol; 1996 Dec; 149(6):2095-106. PubMed ID: 8952542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective platelet-derived growth factor receptor kinase blockers reverse sis-transformation.
    Kovalenko M; Gazit A; Böhmer A; Rorsman C; Rönnstrand L; Heldin CH; Waltenberger J; Böhmer FD; Levitzki A
    Cancer Res; 1994 Dec; 54(23):6106-14. PubMed ID: 7954456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for functional platelet-derived growth factor receptors on MG-63 human osteosarcoma cells.
    Graves DT; Antoniades HN; Williams SR; Owen AJ
    Cancer Res; 1984 Jul; 44(7):2966-70. PubMed ID: 6327031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet-derived growth factor induces proliferation of hyperplastic human prostatic stromal cells.
    Vlahos CJ; Kriauciunas TD; Gleason PE; Jones JA; Eble JN; Salvas D; Falcone JF; Hirsch KS
    J Cell Biochem; 1993 Aug; 52(4):404-13. PubMed ID: 7693727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetics of 125I-PDGF binding and down-regulation of PDGF receptor in arterial smooth muscle cells derived from patients with moyamoya disease.
    Aoyagi M; Fukai N; Matsushima Y; Yamamoto M; Yamamoto K
    J Cell Physiol; 1993 Feb; 154(2):281-8. PubMed ID: 8425908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of growth factor binding, Ca2+ signaling and cell growth by polysulfonated azo dyes related to the antitumor agent suramin.
    Powis G; Seewald MJ; Melder D; Hoke M; Gratas C; Christensen TA; Chapman DE
    Cancer Chemother Pharmacol; 1992; 31(3):223-8. PubMed ID: 1464160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CDGF (chicken embryo fibroblast-derived growth factor) is mitogenically related to TGF-beta and modulates PDGF, bFGF, and IGF-I action on sparse NIH/3T3 cells.
    Geistlich A; Gehring H
    Exp Cell Res; 1993 Feb; 204(2):329-35. PubMed ID: 8440329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Density-dependent inhibitory effect of transforming growth factor-beta 1 on human fibroblasts involves the down-regulation of platelet-derived growth factor alpha-receptors.
    Paulsson Y; Karlsson C; Heldin CH; Westermark B
    J Cell Physiol; 1993 Oct; 157(1):97-103. PubMed ID: 8408247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suramin prevents binding of interleukin 2 to its cell surface receptor: a possible mechanism for immunosuppression.
    Mills GB; Zhang N; May C; Hill M; Chung A
    Cancer Res; 1990 May; 50(10):3036-42. PubMed ID: 1692253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of suramin alone or in combination with DHT and PDGF on the cell proliferation of benign and malignant human prostatic tissues in organ cultures.
    Michel P; Van Velthoven R; Petein M; Gras S; Etievant C; Pasteels JL; Kiss R
    Anticancer Res; 1991; 11(6):2075-8. PubMed ID: 1723262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.